Neurosyphilis Treatment Outcomes After Intravenous Penicillin G versus Intramuscular Procaine Penicillin Plus Oral Probenecid.
Data comparing neurosyphilis treatment regimens are limited. Participants were enrolled in a study of cerebrospinal fluid (CSF) abnormalities in syphilis conducted at the University of Washington between April 2003 to May 2014. They were diagnosed with syphilis and referred by their providers due to concerns for neurosyphilis. One hundred fifty people with CSF abnormalities treated with intravenous aqueous penicillin G (PenG) or intramuscular aqueous procaine penicillin G plus oral probenecid (APPG-P) were evaluated. Abnormal CSF was defined as white blood cells (WBC) >20/µL, CSF protein >50 mg/dL, or reactive CSF Venereal Disease Research Laboratory test (VDRL). Hazard ratios (HR) for normalization of CSF or serum measures were determined using Cox regression. In individuals treated with either PenG or APPG-P, CSF WBCs and CSF-VDRL reactivity normalized within 12 months after treatment, while protein normalized more slowly and less completely. There was no relationship between treatment regimen or HIV status and likelihood of normalization of any measure. Among those with HIV, CSF WBCs and CSF-VDRL reactivity were more likely to normalize in those treated with antiretrovirals. Unexpectedly, CSF WBCs were more likely to normalize in those with low CD4+ T cells. When neurosyphilis was more stringently defined as a reactive CSF-VDRL, the relationship with CD4+ T cell count remained unchanged. In the current antiretroviral treatment era, neurosyphilis treatment outcome is not different for PenG and APPG-P, regardless of HIV status. The relationship between normalization of CSF WBCs and CD4+ T cell count may indicate continued imprecision in neurosyphilis diagnostic criteria due to HIV-related CSF pleocytosis.